Bukowski R - Search Results

1

Phase II trial of liposomal doxorubicin (Doxil) in advanced soft tissue sarcomas.

Chidiac T, Budd GT, Pelley R, Sandstrom K, McLain D, Elson P, Crownover R, Marks K, Muschler G, Joyce M, Zehr R, Bukowski R. Chidiac T, et al. Among authors: bukowski r. Invest New Drugs. 2000 Aug;18(3):253-9. doi: 10.1023/a:1006429907449. Invest New Drugs. 2000. PMID: 10958594 Clinical Trial.

2

Phase I trial of vinorelbine and diphenylhydantoin in patients with refractory carcinoma.

Hutson TE, Ganapathi R, Elson P, Mekhail T, Olencki T, Budd GT, Bukowski RM. Hutson TE, et al. Among authors: bukowski rm. Invest New Drugs. 2004 Aug;22(3):277-84. doi: 10.1023/B:DRUG.0000026253.02502.ce. Invest New Drugs. 2004. PMID: 15122074 Clinical Trial.

3

Phase I trial of continuous infusion recombinant human interleukin-4 in patients with cancer.

Majhail NS, Hussein M, Olencki TE, Budd GT, Wood L, Elson P, Bukowski RM. Majhail NS, et al. Invest New Drugs. 2004 Nov;22(4):421-6. doi: 10.1023/B:DRUG.0000036684.67675.fe. Invest New Drugs. 2004. PMID: 15292712 Clinical Trial.

4

Phase II study of the efficacy and safety of oral GD0039 in patients with locally advanced or metastatic renal cell carcinoma.

Shaheen PE, Stadler W, Elson P, Knox J, Winquist E, Bukowski RM. Shaheen PE, et al. Invest New Drugs. 2005 Dec;23(6):577-81. doi: 10.1007/s10637-005-0793-z. Invest New Drugs. 2005. PMID: 16034517 Clinical Trial.

5

Phase 1 trial of Anvirzel in patients with refractory solid tumors.

Mekhail T, Kaur H, Ganapathi R, Budd GT, Elson P, Bukowski RM. Mekhail T, et al. Among authors: bukowski rm. Invest New Drugs. 2006 Sep;24(5):423-7. doi: 10.1007/s10637-006-7772-x. Invest New Drugs. 2006. PMID: 16763787 Clinical Trial.

6

Phase II trial of circadian infusion floxuridine (FUDR) in hormone refractory metastatic prostate cancer.

Rajagopalan K, Peereboom D, Budd GT, Olencki T, Murthy S, Elson P, McLain D, Bukowski R. Rajagopalan K, et al. Among authors: bukowski r. Invest New Drugs. 1998-1999;16(3):255-8. doi: 10.1023/a:1006195815320. Invest New Drugs. 1998. PMID: 10360605 Clinical Trial.

7

Phase I trial of three-weekly docetaxel, carboplatin and oral lenalidomide (Revlimid) in patients with advanced solid tumors.

Kalmadi S, Davis M, Dowlati A, O'Keefe S, Cline-Burkhardt M, Pelley RJ, Borden E, Dreicer R, Bukowski R, Mekhail T. Kalmadi S, et al. Among authors: bukowski r. Invest New Drugs. 2007 Jun;25(3):211-6. doi: 10.1007/s10637-006-9025-4. Epub 2006 Nov 11. Invest New Drugs. 2007. PMID: 17103043 Clinical Trial.

8

Phase I/II trial of dipyridamole, 5-fluorouracil, leukovorin, and mitoxantrone in metastatic breast cancer.

Budd GT, Herzog P, Bukowski RM. Budd GT, et al. Among authors: bukowski rm. Invest New Drugs. 1994;12(4):283-7. doi: 10.1007/BF00873042. Invest New Drugs. 1994. PMID: 7775128 Clinical Trial.

9

Phase II trial of doxorubicin and trifluoperazine in metastatic breast cancer.

Budd GT, Bukowski RM, Lichtin A, Bauer L, Van Kirk P, Ganapathi R. Budd GT, et al. Among authors: bukowski rm. Invest New Drugs. 1993 Feb;11(1):75-9. doi: 10.1007/BF00873916. Invest New Drugs. 1993. PMID: 8349440 Clinical Trial.

10

A phase I trial of weekly gemcitabine and subcutaneous interferon alpha in patients with refractory renal cell carcinoma.

Perez-Zincer F, Olencki T, Budd GT, Peereboom D, Elson P, Bukowski RM. Perez-Zincer F, et al. Among authors: bukowski rm. Invest New Drugs. 2002 Aug;20(3):305-10. doi: 10.1023/a:1016214030069. Invest New Drugs. 2002. PMID: 12211213 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

529 results

Search Page